Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Mar 28, 2024 07:30 ET
Aspira Women’s Health Reports Fourth Quarter and Full Year 2023 Financial Results
Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today reported its financial results for the fourth quarter and...
Mar 28, 2024 07:30 ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Innoviz Technologies Ltd. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Innoviz Technologies Ltd. (NASDAQ: INVZ)?Did you purchase your shares between April 21, 2021 and February 28, 2023, inclusive?Did you lose money in your investment in Innoviz Technologies...
Mar 28, 2024 07:30 ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Nextdoor Holdings, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Nextdoor Holdings, Inc. (NYSE: KIND)? Did you purchase your shares between July 6, 2021 and November 8, 2022, inclusive? Did you lose money in your investment in Nextdoor Holdings, Inc.?...
Mar 28, 2024 07:30 ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Snowflake Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Snowflake Inc. (NYSE: SNOW)? Did you purchase your shares between September 16, 2020 and March 2, 2022, inclusive? Did you lose money in your investment in Snowflake Inc.? Do you want to...
Mar 28, 2024 07:30 ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds SSR Mining Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of SSR Mining Inc. (NASDAQ: SSRM)? Did you purchase your shares between February 23, 2022 and February 27, 2024, inclusive? Did you lose money in your investment in SSR Mining Inc.?...
Mar 28, 2024 07:30 ET
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx Biosciences, Inc. Investors of Upcoming Deadline
Bernstein Liebhard LLP: Do you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)?Did you purchase your shares pursuant and/or traceable to the Company’s October 21, 2021 IPO, or between October 21, 2021 and November 6, 2023,...
Mar 28, 2024 07:30 ET
Jiayin Group Inc. Reports Fourth Quarter and Fiscal Year 2023 Unaudited Financial Results
Jiayin Group Inc. (“Jiayin” or the “Company”) (NASDAQ: JFIN), a leading fintech platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Operational...
Mar 28, 2024 07:30 ET
Optimi Health Confirms Presenting Sponsorship at the 4th Annual Psychedelic Therapeutics and Drug Development Conference
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical manufacturer, specializing in controlled substances such as natural psilocybin and MDMA, proudly announces its role as a...
Mar 28, 2024 07:30 ET
Theratechnologies to Present Preclinical Data at AACR on Multiple PDCs Showcasing Potential of SORT1+Technology™ Platform
Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced two posters will be presented at the...
Mar 28, 2024 07:30 ET
Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call
Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep related breathing...
Mar 28, 2024 07:15 ET
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences
Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that promote global wellbeing and sustainability, today announced leadership from its business verticals will be...
Mar 28, 2024 07:06 ET
Gilat Awarded $5 Million Order from the US Department of Defense
Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that the US Department of Defense awarded another $5 million order to one of the company’s...
Mar 28, 2024 07:05 ET
Kraig Biocraft Laboratories Shares Industry Update on Recombinant Spider Silk from Waste Plastics
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Kraig Labs" or "the Company"), comments on an exciting advancement in spider silk engineering from the Rensselaer Polytechnic Institute ("RPI"). Researchers at RPI published a paper in Microbial...
Mar 28, 2024 07:05 ET
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that it has entered into a securities purchase...
Mar 28, 2024 07:00 ET
New Report: Visibility Voids Are Exposed When Lacking Insight into Key Data Elements at the Item-Level as the Supply Chain Industry Progresses to End-to-End Traceability
New report from Mojix indicates that item-level inventory traceability has become a priority for companies to stay agile and competitive in the global marketplace. Released today, “Enhancing Supply Chain Resilience: The Advantages of Supply Chain...
Mar 28, 2024 07:00 ET
Shimmick Corporation Announces Fourth Quarter and Fiscal Year 2023 Results
Shimmick Corp. (NASDAQ: SHIM), a leading water infrastructure company, today announced financial results for the fiscal year ended December 29, 2023. Fiscal Year 2023 Highlights Completed Initial Public Offering in November...
Mar 28, 2024 07:00 ET
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”) a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced fourth quarter and full year 2023 financial results and provided...
Mar 28, 2024 07:00 ET
Apollomics Highlights Clinical Progress and Reports Full Year 2023 Financial Results
Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late- stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced financial...
Mar 28, 2024 07:00 ET
ARKO Corp. Negotiates Enhanced Value for Stockholders in Final Payment for TEG Acquisition
ARKO Corp. (Nasdaq: ARKO) (“ARKO” or the “Company”), a Fortune 500 company and one of the largest convenience store operators in the United States, announced today that it has negotiated improved deferred payment terms and value related to the...
Mar 28, 2024 07:00 ET
Aya Gold & Silver: Record 2023 Production, Revenue and Operating Cash Flow
Aya Gold & Silver Inc. (TSX: AYA, OTCQX: AYASF) (“Aya” or the “Corporation”) is pleased to announce financial and operational results for the fourth quarter and year ended December 31, 2023. All amounts are in US dollars, unless otherwise stated....